B7-H3 mRNA expression has been found in multiple human tissues and cell lines, such as prostate cancer, non-small-cell lung carcinoma, and RCC [20], and B7-H3 has been implicated as a potential inhibitor of T-cell activity [21]. This evidence concerns the gene CD276 and prostate cancer.